HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hélène Péré Selected Research

COVID-19 Vaccines

1/2022Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
1/2021Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hélène Péré Research Topics

Disease

25COVID-19
05/2024 - 01/2020
12Infections
10/2023 - 02/2014
6Papillomavirus Infections
10/2023 - 01/2018
6Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 01/2019
3Breakthrough Infections
01/2023 - 11/2022
3Neoplasms (Cancer)
04/2021 - 09/2009
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2023 - 01/2023
2Carcinoma (Carcinomatosis)
01/2021 - 09/2020
2Papilloma (Papillomatosis)
01/2021 - 10/2020
2Squamous Cell Carcinoma of Head and Neck
01/2020 - 11/2018
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 01/2018
1Chronic Renal Insufficiency
12/2023
1Pneumonia (Pneumonitis)
01/2023
1Emerging Communicable Diseases (Emerging Infectious Diseases)
12/2022
1Critical Illness (Critically Ill)
05/2022
1Fever (Fevers)
01/2022
1COVID-19 rebound
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2021
1Cytokine Release Syndrome
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
11/2020
1Bacterial Pneumonia
11/2020
1Autoimmune Diseases (Autoimmune Disease)
11/2020
1Lymphopenia (Lymphocytopenia)
11/2020
1Acquired Immunodeficiency Syndrome (AIDS)
05/2020
1Oropharyngeal Neoplasms
01/2020
1Disease Progression
01/2020
1Inflammation (Inflammations)
01/2020
1Carcinogenesis
11/2019
1Anus Neoplasms (Anal Cancer)
01/2019
1Herpes Genitalis (Genital Herpes)
05/2014
1Syphilis
12/2013

Drug/Important Bio-Agent (IBA)

9DNA (Deoxyribonucleic Acid)IBA
10/2023 - 02/2014
8Monoclonal AntibodiesIBA
05/2023 - 11/2020
7VaccinesIBA
10/2023 - 01/2019
7RNA (Ribonucleic Acid)IBA
01/2023 - 01/2018
5Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2018
5AntibodiesIBA
01/2022 - 12/2013
5Immunoglobulin G (IgG)IBA
01/2021 - 01/2020
3Neutralizing AntibodiesIBA
10/2023 - 01/2021
3N-(2-cyanoethylene)urea (BA 1)IBA
01/2023 - 11/2022
3N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023 - 11/2022
3Immunoglobulin M (IgM)IBA
01/2021 - 11/2020
2CytokinesIBA
05/2024 - 11/2021
2tixagevimabIBA
05/2023 - 12/2022
2cilgavimabIBA
05/2023 - 12/2022
2Antiviral Agents (Antivirals)IBA
05/2022 - 05/2014
2COVID-19 VaccinesIBA
01/2022 - 01/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2024
1nirmatrelvirIBA
12/2023
1Ritonavir (Norvir)FDA Link
12/2023
1nirmatrelvir and ritonavir drug combinationIBA
05/2023
1imdevimabIBA
05/2023
1sotrovimabIBA
05/2023
1casirivimabIBA
05/2023
1Peptide Hydrolases (Proteases)FDA Link
05/2023
1InterferonsIBA
01/2023
1Oxygen (Dioxygen)IBA
01/2023
1Immunoglobulin A (IgA)IBA
12/2022
1BNT162 VaccineIBA
12/2022
1cilgavimab and tixagevimab drug combinationIBA
12/2022
1casirivimab and imdevimab drug combinationIBA
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1Ribonuclease P (RNase P)IBA
01/2022
1Nucleocapsid ProteinsIBA
05/2021
1AntigensIBA
05/2021
1Bevacizumab (Avastin)FDA Link
04/2021
1PlatinumIBA
04/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2021
1olaparibIBA
04/2021
1Carboplatin (JM8)FDA LinkGeneric
04/2021
1Paclitaxel (Taxol)FDA LinkGeneric
04/2021
1Cholinergic Agents (Cholinergics)IBA
01/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2021
1Eosine Yellowish-(YS) (Eosin)IBA
01/2021
1Hematoxylin (Haematoxylon)IBA
01/2021
1NicotineFDA Link
01/2021
1Nucleic AcidsIBA
11/2020
1Messenger RNA (mRNA)IBA
10/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Interferon Type IIBA
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
11/2019
1Viral DNAIBA
11/2019
1ParaffinIBA
01/2019
1NucleotidesIBA
01/2019
1Formaldehyde (Formol)FDA Link
01/2019
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2018

Therapy/Procedure

7Therapeutics
05/2022 - 09/2009
1Secondary Prevention
12/2022
1Aftercare (After-Treatment)
12/2022
1Chemoradiotherapy
04/2021
1Artificial Respiration (Mechanical Ventilation)
11/2020